STONKWHISPER
← Back to Intel
Insider ActivityBBIO

Kumar Neil, Chief Executive Officer, Director at BridgeBio Pharma, Inc., traded $2.4M of BBIO

Updated Jun 21, 2026
Kumar Neil Chief Executive Officer, Director
BridgeBio Pharma, Inc. · $BBIO
$2.4M Total Value
36,236 Shares Traded
$66.13 Price / Share
269,430 Shares Owned After
2026-05-19 Filing Date

Transaction Details

InsiderKumar Neil
TitleChief Executive Officer, Director
CompanyBridgeBio Pharma, Inc.
TickerBBIO
Transaction TypeTax
Transaction Date2026-05-16
Shares Traded36,236
Price Per Share$66.13
Total Value$2.4M
Filed Date2026-05-19
Accession Number0001470831-26-000472

Ownership Context

Shares Owned After Transaction269,430
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001470831-26-000472

Other Insider Trades — BBIO

Other Trades by Kumar Neil

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for BBIO — BridgeBio Pharma, Inc. →

Track BBIO insider activity in real time on The Wire →

Get alerts when Kumar Neil files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 21, 2026 at 07:12 UTC

Want real-time data? Access The Wire for live sentiment tracking.